| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Comprehensive loss | -10,069 | -7,892 | ||
| Earnings per share, basic | -0.12 | -0.1 | ||
| Earnings per share, diluted | -0.12 | -0.1 | ||
| Weighted average number of shares outstanding, basic | 82,836,369 | 77,774,344 | ||
| Weighted average number of shares outstanding, diluted | 82,836,369 | 77,774,344 | ||
Corvus Pharmaceuticals, Inc. (CRVS)
Corvus Pharmaceuticals, Inc. (CRVS)